EN
  • FR
Contact
  • News
  • Contact
  • CAREERS
LFB Biomanufacturing
  • About
    • About LFB BIOMANUFACTURING
    • Our assets
    • ESCAPE30: our New development strategy
    • THEY APPRECIATE OUR SERVICES
    • About the LFB Group
  • Development services
    • Cell line development and banking
    • EMABling® platform
    • Process development and scale up
  • Manufacturing services
    • GMP manufacturing
    • Innovative facility
  • Analytical services
    • Formulation
    • Bioassay Development
    • Analytics
  • About LFB BIOMANUFACTURING

    LFB BIOMANUFACTURING is a CDMO specialising in the manufacture of recombinant proteins and monoclonal antibodies.

  • Our assets

    AN EXPERIENCED TEAM, WORKING WITH AGILITY AND UNDERSTANDING CHALLENGES OF BIOLOGICALS: LFB BIOMANUFACTURING has strong assets for your projects

  • ESCAPE30: our New development strategy

    In November 2022 the leadership team  of LFB BIOMANUFACTURING met with aim to precise the strategic path of the company, referred to as ESCAPE30

  • THEY APPRECIATE OUR SERVICES

    Why will you select LFB BIOMANUFACTURING as you preferred partner?

  • About the LFB Group

    LFB group, a pharmaceutical company specialising in biological medicinal products

  • Cell line development and banking

    Two CLD platforms are currently available at LFB BIOMANUFACTURING: a CHO-S  (Life Technology) platform, and EMABling® proprietary platform.

  • EMABling® platform

    A proprietary platform for monoclonal antibodies with enhanced ADCC

  • Process development and scale up

    Services for process development and scale-up

  • GMP manufacturing

    GMP Manufacturing services for recombinant medicinal products

  • Innovative facility

    Flexibility, disposable-oriented, LFB BIOMANUFACTURING’s commitments for tomorrow

  • Formulation

    LFB has extensive experience in the successful development of formulations for monoclonal antibodies and highly complex proteins.

  • Bioassay Development

    Collaborate with us to develop specific cell-based bioassay.

  • Analytics

    A unique in house expertise in analytical development for biologics.

Des médicaments
commercialisés dans
plus de 40 pays

burger

Accueil › Development services

DEVELOPMENT SERVICES

LFB BIOMANUFACTURING offers development services, from pre-clinical to clinical stages : cell line development and banking, process development and scale-up. LFB’s proprietary platform EMABling® allows LFB BIOMANUFACTURING to propose specific developments for high-ADCC monoclonal antibodies.

Cell line development and banking

Two CLD platforms are currently available at LFB BIOMANUFACTURING: a CHO-S  (Life Technology) platform, and EMABling® proprietary platform.

Learn more

EMABling® platform

EMABling® platform (YB2/0 cell line) to develop and manufacture monoclonal antibodies with enhanced ADCC function.

Learn more

Process development and scale up

Cell culture process development, media optimization and yield improvement, downstream process development…

Learn more

Follow us on

  • About
    • About LFB BIOMANUFACTURING
    • Our assets
    • ESCAPE30: our New development strategy
    • THEY APPRECIATE OUR SERVICES
    • About the LFB Group
  • Development services
    • Cell line development and banking
    • EMABling® platform
    • Process development and scale up
  • Manufacturing services
    • Innovative facility
    • GMP manufacturing
  • CAREERS
  • Site map
  • Information notices
 

 

×